Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial on Pharmacokinetic and Tolerability of AP701

NCT04708795 is registered in ClinicalTrials.gov with CannaXan GmbH as lead sponsor.

NCT NCT04708795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial on Pharmacokinetic and Tolerability of AP701
Lead sponsor
CannaXan GmbH
Phase
Phase 1
Overall status
Completed
Start date
January 11, 2020
Completion date
March 7, 2021
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetic, safety, tolerability